1778 related articles for article (PubMed ID: 12147618)
41. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
[TBL] [Abstract][Full Text] [Related]
42. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.
Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967
[TBL] [Abstract][Full Text] [Related]
43. Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage.
Hua Y; Xi G; Keep RF; Wu J; Jiang Y; Hoff JT
J Cereb Blood Flow Metab; 2002 Jan; 22(1):55-61. PubMed ID: 11807394
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
45. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
46. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
Ramsby ML; Kreutzer DL
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
[TBL] [Abstract][Full Text] [Related]
47. Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin.
Grant MB; Guay C
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):53-64. PubMed ID: 1702773
[TBL] [Abstract][Full Text] [Related]
48. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
49. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
Nordt TK; Lutzi S; Ruef J; Peter K; Klar E; Kübler W; Sobel BE; Bode C
Thromb Haemost; 2001 Nov; 86(5):1305-13. PubMed ID: 11816722
[TBL] [Abstract][Full Text] [Related]
50. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1.
Boehm JR; Kutz SM; Sage EH; Staiano-Coico L; Higgins PJ
J Cell Physiol; 1999 Oct; 181(1):96-106. PubMed ID: 10457357
[TBL] [Abstract][Full Text] [Related]
51. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
52. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
53. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
54. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
55. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
56. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928
[TBL] [Abstract][Full Text] [Related]
57. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
58. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells.
Kasza A; Kowanetz M; Poślednik K; Witek B; Kordula T; Koj A
Cytokine; 2001 Dec; 16(5):187-90. PubMed ID: 11814314
[TBL] [Abstract][Full Text] [Related]
60. Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats.
Liang W; Chuan-Zhen L; Qiang D; Jian Q; Hui-Min R; Bao-Guo X
Brain Res; 2004 Jul; 1015(1-2):175-80. PubMed ID: 15223382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
